Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.


TSXV:VM - Post by User

Post by WarrantOfficeron Mar 04, 2021 8:54am
243 Views
Post# 32713275

Where from here?

Where from here?Great that we have 2 HC approvals. Where does this get us? Management must keep the momenteum moving forward. Do not want the stock to slide as this will jepordize any future financing. IMO, three key take aways from their website Voyageur Deck Nov 2020 

Voyageur and ThinQ in negotiations with Indian Contract Manufacturing Companies to begin immediate sales in the Indian market for iodine products - Sales targeted for 2021. When in 2021?

FDA applications for barium contrast will be filed with use of proceeds from financing: • Consultants in place. • FDA waiving fees on first product application - an update on FDA applications?

AVL Calgary facility to produce barium contrast, marketing and sales - renovations and upgrades were scheduled for completion the end of Jan 2021 and are supply lines pre-established?


<< Previous
Bullboard Posts
Next >>